AIBioTech to Use AutoGenomics Analyzer in its CRO Services | GenomeWeb

NEW YORK (GenomeWeb News) – American International Biotechnology Services will use AutoGenomics' Infiniti Analyzer and validated applications in its molecular biology, microbiology, and other services, AutoGenomics said today.

A division of Bostwick Laboratories, AIBioTech provides molecular diagnostic, proteomics, and other research and product development services.

"The versatility of our BioFilmChip Microarray technology allows us to rapidly develop new applications to meet the needs of AIBioTech," AutoGenomics CEO Fareed Kureshy said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.